Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether pediatric participants with irritability associated with autistic disorder who have responded to aripiprazole treatment will experience a relapse significantly later when continuing therapy with aripiprazole than will participants who receive placebo


Clinical Trial Description

Phase 1: Single blind/ Phase 2: Double blind ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01227668
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Completed
Phase Phase 4
Start date March 2011
Completion date June 2012